ArticlePlant biotechnology journal2025
Enhancing melatonin biosynthesis in crops through synthetic genetic circuits: A strategy for nutritional fortification in soybean and stress resistance in cotton.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Melatonin-enabled omics: understanding plant responses to single and combined abiotic stresses for climate-smart agriculture.GM crops & food · 2026Review
- Turbocharging crop breeding with integrated biotechnology for a climate-resilient future.Journal of integrative plant biology · 2026Review
- Integrating AI in seed science: Toward an intelligent design paradigm.Plant communications · 2026Review
- Molecular insights into melatonin-mediated stress tolerance in rice.Plant cell reports · 2025Review
- Melatonin and Grain Legume Crops: Opportunities for Abiotic Stress Tolerance Enhancement and Food Sustainability.Plants (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Melatonin has gained considerable prominence in the treatment of insomnia that significantly impacts one-third of the global population. The production of melatonin remains challenging due to limitations in current methods. Thus, there is an urgent need for developing more efficient and innovative production techniques. Here, we demonstrated the potential of crop seeds as a platform for melatonin synthesis by engineering multiple BUFFER genetic circuits using synthesized transcriptional regulators, which enhance expression precision, orthogonality and thresholds. Biofortified soybeans exhibited a 31-fold increase in melatonin content compared to standard Williams 82, without detrimental impact on yield. Protein content was elevated, oil content reduced and the soybeans were suitable for post-harvest processing. Furthermore, plants enriched in endogenous melatonin exhibited stronger resilience to adversity, evidenced by improved salinity tolerance in soybean seeds and increased resistance to Verticillium dahliae in cotton. Our research paves the way for the synthesis of target compounds in staple crops using synthetic genetic circuits, facilitating the development of novel biofortified crops to increase nutritional availability and environmental adaptability in the upcoming new era of agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.